companydata.dkcompanydata.dk

Incyte Biosciences Denmark ApS: Financial statements 2020

CVR: 35818790

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

Incyte Biosciences Denmark ApS (CVR 35818790) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 5,397,378 and a net result of DKK 150,425 compared with DKK 285,661 the year before. That is an increase of 11.7% compared with the year before. Equity in the 2020 report amounted to DKK 677,409. The solvency ratio was 20.1%. The company had 3 employees in the financial year.

Gross Profit
DKK 5,397,378
Profit/Loss
DKK 150,425
Equity
DKK 677,409
Total Assets
DKK 3,371,054
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-5.4M150K677K3
2019-4.8M286K527K3
2018-3M87K241K2
2017-2M47K154K1
2016-1.5M25K107K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Incyte Biosciences Denmark ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Incyte Biosciences Denmark ApS: The 2019 annual report is outMay 20, 2020

Incyte Biosciences Denmark ApS has published its annual report for 2019. Gross profit came to DKK 4,829,925, and the net result was DKK 285,661.

About Incyte Biosciences Denmark ApS

Incyte Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ARIAD PHARMACEUTICALS (DENMARK) ApS. The management consists of Ebba Cecilia Bröms. The board consists of Lee Jason Heeson (chair) and Ebba Cecilia Bröms. The company is owned by Incyte Biosciences International Sàrl. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 6,696,586 and a net result of DKK 361,151 compared with DKK 368,873 the year before. Equity in the 2025 report amounted to DKK 2,328,496.

Source: annual report 2025, Danish Business Authority